A dramatic complication of a subcutaneous implantable cardioverter-defibrillator test: the difficult management of patients and devices when atrial fibrillation and heart failure coexist.
作者信息
Fumagalli Stefano, Nigro Francesca Maria, Palumbo Vanessa, Marozzi Irene, Lamassa Maria, Pieragnoli Paolo
机构信息
Geriatric Intensive Care Unit and Geriatric Arrhythmia Unit, University of Florence and AOU Careggi, Viale Pieraccini 6, Florence, Italy.
Stroke Unit, University of Florence and AOU Careggi, Florence, Italy.
出版信息
Europace. 2020 Jan 1;22(1):46. doi: 10.1093/europace/euz217.
PMID:31389565
Abstract
摘要
相似文献
1
A dramatic complication of a subcutaneous implantable cardioverter-defibrillator test: the difficult management of patients and devices when atrial fibrillation and heart failure coexist.皮下植入式心律转复除颤器测试的一种严重并发症：心房颤动与心力衰竭并存时患者和设备的棘手管理
Europace. 2020 Jan 1;22(1):46. doi: 10.1093/europace/euz217.
2
Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.心力衰竭合并心房颤动患者心脏再同步治疗的比较效果：来自国家心血管数据注册中心植入式心律转复除颤器注册研究的结果
Circ Heart Fail. 2016 Jun;9(6). doi: 10.1161/CIRCHEARTFAILURE.115.002324.
3
Diagnostic capabilities of devices for cardiac resynchronization therapy.心脏再同步治疗设备的诊断能力。
J Cardiovasc Med (Hagerstown). 2010 Mar;11(3):186-9. doi: 10.2459/JCM.0b013e3283303036.
4
Remote Monitoring for Chronic Disease Management: Atrial Fibrillation and Heart Failure.慢性病管理的远程监测：心房颤动与心力衰竭
Card Electrophysiol Clin. 2018 Mar;10(1):43-58. doi: 10.1016/j.ccep.2017.11.005.
5
The role of atrial sensing for new-onset atrial arrhythmias diagnosis and management in single-chamber implantable cardioverter-defibrillator recipients: Results from the THINGS registry.单腔植入式心律转复除颤器受者中新发房性心律失常诊断和管理中心房感知的作用：来自 THINGS 注册研究的结果。
J Cardiovasc Electrophysiol. 2020 Apr;31(4):846-853. doi: 10.1111/jce.14396. Epub 2020 Feb 25.
6
Detection of heart failure decompensation using intrathoracic impedance monitoring by a triple-chamber implantable defibrillator.使用三腔植入式除颤器通过胸内阻抗监测来检测心力衰竭失代偿。
Heart Rhythm. 2005 Sep;2(9):997-9. doi: 10.1016/j.hrthm.2005.06.005.
7
Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy).卡维地洛和美托洛尔对植入式心律转复除颤器不适当治疗的影响：MADIT-CRT 试验（心脏再同步治疗的多中心自动除颤器植入）。
J Am Coll Cardiol. 2013 Oct 8;62(15):1343-50. doi: 10.1016/j.jacc.2013.03.087. Epub 2013 Jun 13.
8
Double jeopardy in an implantable cardioverter defibrillator patient.植入式心脏复律除颤器患者的双重风险。
J Cardiovasc Electrophysiol. 2003 Jul;14(7):784. doi: 10.1046/j.1540-8167.2003.02561.x.
9
Value of implantable cardioverter-defibrillators in managing atrial fibrillation.植入式心脏复律除颤器在房颤治疗中的价值。
Heart Rhythm. 2009 Jan;6(1):9-10. doi: 10.1016/j.hrthm.2008.10.009. Epub 2008 Oct 11.
10
More bad news for cardiac resynchronization therapy in atrial fibrillation patients: what to do?心房颤动患者心脏再同步治疗的更多坏消息：该怎么办？
J Cardiovasc Electrophysiol. 2013 Oct;24(10):1123-4. doi: 10.1111/jce.12242. Epub 2013 Sep 9.
Zotero 插件